🇺🇸 FDA
Patent

US 9994817

Use of ligands for the programmed cell death receptor conjugated to solid supports for cultivating human regulatory T cells

granted A61KA61K40/11A61K40/22

Quick answer

US patent 9994817 (Use of ligands for the programmed cell death receptor conjugated to solid supports for cultivating human regulatory T cells) held by Northwestern University expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K40/11, A61K40/22, A61K40/416, A61P